La OMS recomienda priorizar la vacunación en adultos antes que a los niños nuevodiarioweb.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nuevodiarioweb.com.ar Daily Mail and Mail on Sunday newspapers.
Reuters
Asia-Pacific economies are racing to develop home-grown Covid-19 vaccines as supply shortages threaten to upend containment efforts and prolong the pandemic.
Japan, South Korea, India, Taiwan, Thailand, Indonesia and Vietnam are all betting on multiple locally developed vaccine candidates after struggling to secure adequate supplies of shots from overseas.
Although locally developed vaccines are unlikely to arrive in time to save sluggish vaccine roll-outs, authorities and scientific experts regard the approach as a longer-term investment.
Many experts expect Covid-19 to circulate indefinitely. It means the emergence of variants resistant to existing vaccines and the potential need for booster shots to maintain immunity could fuel vaccine demand for years to come.
Trials of homegrown COVID-19 vaccine show positive signs Chia sẻ | FaceBookTwitter Email Copy Link Copy link bài viết thành công
05/06/2021 14:28 GMT+7
The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass production begins.
Doctor prepares to inject Nano Covax COVID-19 vaccine on a volunteer. (Photo: VNA)
Following the clinical trials of Phase 2, which lasted three months, all volunteers experienced an increase in antibody levels against the coronavirus. This is a positive sign that not only makes it possible for developers to safely speed up Phase 3 but also raises hopes that a Made-in-Vietnam vaccine will soon become available amid the growing complexity of the pandemic both locally
Update: June, 05/2021 - 09:55 |
Minister of Health Nguyễn Thanh Long (left) receives 30 COVID-19 breath testing system donated by Vingroup on Friday. Photo moh.gov.vn
HÀ NỘI Local conglomerate Vingroup has successfully reached a deal with Singaporean firm Breathonix to bring to Việt Nam a COVID-19 breath testing system costing over VNĐ460 billion (US$20 million).
Comprising 30 testing machines and disposable mouthpieces capable of collecting 2 million samples, the system will be handed over to the Ministry of Health (MoH) upon its arrival in the country.
The BreFence™ Go COVID-19 breath testing system quickly produces results in an accurate and non-invasive manner. The test has received provisional authorisation from Singapore’s Health Sciences Authority (HSA).